Connect with us

All about Cannabis

Poilievre Misdiagnoses Opioid Crisis – Cannabis | Weed | Marijuana

Published

on


Conservative Party leader Pierre Poilievre misdiagnoses the opioid crisis in the latest video, “Everything Feels Broken.”

In the five-minute video, Poilievre uses a Vancouver tent city as his backdrop to make a case for the drug war.

For a decade, British Columbia (among other Canadian cities) has provided a clean, safe supply of drugs for the addicted.

He calls it a “failed experiment” brought in by “woke Liberal and NDP governments,” before saying he’ll end this policy and instead put taxpayers’ money into recovery and treatment.

The narrative is easy to follow: there is a correlation between safe supply sites and opioid deaths. Ergo, one caused the other.

Unfortunately, data doesn’t support this narrative. Nor does the data support Poilievre’s claim that Alberta‘s anti-drug policy has worked better.

(In fact, how Alberta deals with opioids isn’t all that different from the rest of the country, including having safe supply sites in Edmonton and Calgary).

But if you want to critique Poilievre’s video, there are plenty of articles on this topic.

Most critics, however, defend safe supply sites, claim compassion for addicts, and, far from engaging with Poilievre on his ideas, merely parrot federal Addictions Minister Carolyn Bennett by calling the video “irresponsible” and “misguided.”

Pierre Poilievre is wrong about the cause of drug overdose deaths in Canada. And, like his critics, he’s also wrong about throwing money at “treatment and recovery.”

Just as his critics are wrong that taxpayer-funded “safe supply” is the way out of the crisis.

How Poilievre (And his Critics) Misdiagnose the Opioid Crisis

Poilievre Misdiagnoses Opioid Crisis

When Poilievre misdiagnoses the opioid crisis, it comes from a place of politics. His goal is to acquire Justin Trudeau’s PMO power, which has significantly increased since the Harper years.

Therefore, when ordinary families are facing a shortage of children’s pain medication, it’s apt time to go after the taxpayer-funded supply of hard drugs.

Especially since a decade of “safe supply” hasn’t produced immediate results.

Now, critics are right to point out that, in B.C., over 80% of overdoses don’t occur in the street but in a private residence or shelter. The problem is less about homeless people dying in the streets than the toxicity of street drugs.

That’s why safe supply sites work, say the supporters.

And Poilievre isn’t opposed to using taxpayer money to fund treatment policies. He disagrees with the means.

But in a discussion about Poilievre’s “Everything Feels Broken” video, almost no one has mentioned the elephant in the room: the corporate pharmaceutical conglomerates.

They caused the opioid crisis and profit from supplying methadone and Suboxone to safe supply sites.

Poilievre critics would be wise to stop with the surface-level attacks and get to the core of the issue. And Poilievre’s supporters would be wise to question their leader’s motives and proposed solutions.

If you want a villain, look no further than McKinsey & Company.

How McKinsey & Company Caused the Opioid Crisis

Poilievre Misdiagnoses Opioid Crisis

McKinsey & Company is a global management consulting firm. They’ve been around since the 1920s and are considered one of the “Big Three” consulting agencies worldwide.

They’ve also been involved in many controversies, from Enron, the ’08 financial crisis, insider trading, conflicts of interest, and associations with murderous dictators, including Saudi Arabia.

So it shouldn’t be a surprise they’ve played a role in the opioid epidemic.

McKinsey & Company wanted to “turbocharge” Oxycontin sales. They proposed strategies to combat the messages from real parents who lost their children to Oxy overdoses.

They also advised opioid makers on how to circumvent government regulations.

They’re the type of firm to crunch the numbers and figure out that it’s cheaper to pay $36.8 million to the families who’ve lost someone from an overdose than to stop selling the toxic crap.

In 2018/19, McKinsey & Company collected over $400 million by consulting pharmaceutical companies.

McKinsey’s services turned Endo from a small generic opioid manufacturer to one of the world’s largest opioid businesses.

McKinsey also recommended targeting and influencing doctors. They wanted elderly and long-term care patients hooked on opioids.

They’re staffed by a revolving door of consultants who either come from (or go on to work for) government regulators like the FDA and pharmaceutical clients like Purdue.

Purdue Pharma went into bankruptcy and had to pay a multi-billion-dollar settlement because it “intentionally conspired and agreed with others to aid and abet” the over-prescribing of painkillers “without a legitimate medical purpose.”

The idiom “the fox is guarding the henhouse,” has never been more relevant.

Poilievre spends five minutes criticizing his political opponents instead of the corporate-state cartel that has brought us to this point. That’s when you know Poilievre is misdiagnosing the opioid crisis.

Poilievre Misdiagnoses Opioid Crisis

While Poilievre misdiagnoses the opioid crisis, he does mention in passing the doctors who “prescribed and over-prescribed,” opioids.

For someone who goes on about gatekeepers, you’d think Poilievre could put two and two together. Yet, this was far as he went with that line of criticism.

If Poilievre wants to go after Justin Trudeau, why not point out that our blackface PM made a McKinsey crony (Dominic Barton) Canada’s ambassador to China in 2019?

(Although, in Justin’s defence, you could argue that dealing with a murderous regime that doesn’t believe in the sanctity of human life requires an ambassador who feels the same way).

Like most of Poilievre’s critiques of government, he misdiagnoses the opioid crisis by not going deeper into the issue and pointing fingers at his political opposition instead of the merging of corporate and state power.

And why would he?

Like Liberal and NDP governments, Conservatives adhere to lobbying concerns more than their constituents.

And when constituents get rowdy, like organizing an occupation in the nation’s capital, the corporate press is there to propagate a narrative that fools the masses and protects the financial interests of the elite.

That’s where critics on both sides fail to grasp the nature of the opioid crisis. Not only did pharmaceutical corporations cause this crisis (with help from the state), but they also profit from the proposed “solutions,” including safe supply.

So what’s the answer?

How Poilievre Can Reverse His Misdiagnoses of the Opioid Crisis

Poilievre Misdiagnoses Opioid Crisis

In his “Everything feels broken” video, where Poilievre misdiagnoses the opioid crisis, he proposes statist solutions like toughening security at the border to keep illegal drugs out of the country.

That’s obviously unrealistic. You’d have to claim complete ignorance of the global fentanyl trade to believe “strengthening the border” would work.

Further, Poilievre says, “There is no safe supply of these drugs.”

Indicating that even if we rid the country of killer opioids like fentanyl and carfentanyl, we’d still have a drug problem.

As if the mere existence of an opioid is enough to justify the drug war.

You won’t find the correct solution from Poilievre’s brand of quasi-libertarian politics. And you won’t find an answer from the various left-wing parties who have never found a problem more government spending couldn’t fix.

Politicians know who butters their bread. Additionally, cultural norms and attitudes about drugs shape our thinking.

But no matter how you slice it: no one has a right to your body except you.

Taken to its logical conclusion, someone throwing you in a cage for consuming opioids is an aggressor and a tyrant.

Meaning, the solution to Canada’s opioid crisis is to legalize heroin.

Legalizing “Hard” Drugs

Photo credit: Trey Patric Helten

Is there a difference between “hard” drugs like heroin and “soft” drugs like cannabis? Is one more addictive than the other? What about alcohol? Is that a “hard” or “soft” drug?

Perhaps the distinction itself is arbitrary.

Some drugs are more dangerous than others. Just as riding a motorcycle is more dangerous than driving a car. 

Too much of our conversation surrounding drugs, especially opioids, is wrapped up in language about “losing control” and “involuntarily behaviour.”

But this narrative is entirely false. Just as there are responsible cannabis consumers, there are responsible opioid consumers.

Problems arise when people behave according to the ideas they have about drugs. No one is living on the street and committing crimes to get their hands on refined sugar.

But if you limit the supply of the sweet stuff, I can guarantee you societal chaos is around the corner.

A refined sugar prohibition would incentive an illegal supply of sugar. And cutting that white powder with non-sugar is a sketchy but efficient way to boost profits.

Would the solution be to put sugar addicts into rehab centres where they lose whatever autonomy they have left?

Or would the solution be to set up clinics where the people jonesing the hardest could go for a safe supply?

Or is the solution legalizing all sugar and letting individuals decide what is best for them?

Poilievre misdiagnoses opioid crisis. But so do his critics. The answer is obvious. It’s only drug war propaganda that keeps us from seeing it. 





Source link

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

alcohol abuse

More Weed, More Problems? – Cannabis | Weed | Marijuana

Published

on

By


More weed, more problems? As in, if you smoke all day, everyday, your life is likely a hot mess with no hope of redemption? According to recent research from CU Boulder, the answer to “more weed, more problems” is no.

According to researchers, legalizing recreational cannabis at the state level does not lead to an increase in substance use disorders. Or even increased use of illicit drugs among adults. In fact, it may even decrease issues related to alcohol abuse.

A study involving over 4,000 twins from Colorado and Minnesota found no correlation between cannabis legalization and any increases in cognitive, psychological, social, relationship, or financial problems.

“We really didn’t find any support for a lot of the harms people worry about with legalization,” said lead author Stephanie Zellers. “From a public health perspective, these results are reassuring.”

The study, published in Psychological Medicine, was conducted by researchers from the University of Minnesota, CU Boulder and the CU Anschutz Medical Campus. The study used data from two of the nation’s most extensive and longest-running twin studies: one located at IBG and the other at the Minnesota Center for Twin Family Research.

What Are Twin Studies? 

More Weed, More Problems?

Can twin studies prove that more weed doesn’t equal more problems? Well, what are twin studies?

Twin studies are research designs that compare identical (monozygotic) and fraternal (dizygotic) twins. The idea is that identical twins share all their genes, while fraternal twins share only about half of their genes.

So any differences between the two types of twins can help researchers identify which traits or conditions are likely influenced by genetics and which are likely influenced by environment. Researchers can use twin studies to study a wide range of topics, including genetics, development, and health.

IBG stands for Institute of Behavioral Genetics, a research center at the University of Colorado Boulder. The Minnesota Center for Twin Family Research located at the University of Minnesota.

Both centers conduct twin studies and have been collecting data over the years. And both centers are among the nation’s most prominent and longest-running twin studies. They provide researchers with a wealth of data on genetic and environmental factors related to human behaviour and development.

The Problem with Twin Studies

Of course, Twin studies are not without their critics.

  1. Assumption of equal environments: Twin studies sometimes assume that identical and fraternal twins are raised in similar environments, but this may not always be the case. For example, identical twins may be treated more similarly than fraternal twins, which could affect the results.
  2. Limited generalizability: Researchers often conduct twin studies on small, specific samples, such as twins from a particular country or region. This limits the generalizability of the findings to other populations.
  3. Missing heritability: Twin studies estimate the proportion of variation in a trait or condition due to genetics. But they do not account for all the genetic variation that may influence the trait or condition.
  4. Complexity of human behaviour: Many complex human behaviours and conditions, such as mental disorders or intelligence, likely result from multiple genes and environmental factors. Twin studies may not fully capture these interactions.
  5. Selection bias: Twins who volunteer for studies might differ from twins who do not volunteer, which can bias the results.

Twin Studies Disprove More Weed, More Problems? 

More Weed, More Problems?

The researchers of this “more weed, more problems” study compared the 40% of twins who reside in states where recreational cannabis is legal to those who live in states where it remains illegal to understand the overall impact of legalization.

Researchers have been tracking the participants, who are now between the ages of 24 and 49, since their adolescence. They’ve been gathering information on their use of alcohol, tobacco, cannabis and several other illicit drugs, as well as assessing their overall well-being.

By specifically comparing twins within 240 pairs, in which one twin lives in a state with legal cannabis and the other where it is not, the researchers aimed to identify any changes caused by cannabis legalization.

The researchers previously found that identical twins residing in states where recreational cannabis is legal tend to use it around 20% more often than their twins living in states where it remains illegal.

So does that mean more weed, more problems?

To answer this question, the team compared survey results that examined 23 indicators of “psychosocial distress.” Including the use of alcohol and illicit drugs like cocaine and heroin, psychological distress, financial difficulties, cognitive issues, unemployment, and relationship issues both at home and at work.

“We included everything we had data on with the goal of getting a well-rounded look at the impacts on the whole person,” said Zellers. “Big picture, there’s not much there.”

No, More Weed Does Not Equal More Problems

More Weed, More Problems?

So is “more weed, more problems” debunked?

Researchers found no relationship between legal cannabis and an increased risk of “cannabis use disorder” or dependency.

For years, critics have called cannabis a “gateway” drug to harder substances like cocaine and heroin. The researchers found no changes post-legalization.

“For low-level cannabis use, which was the majority of users, in adults, legalization does not appear to increase the risk of substance use disorders,” said co-author Dr. Christian Hopfer.

Not only does this study question the “more weed, more problems” narrative, but it also shows legal cannabis’ benefit. People in legal states are less likely to develop alcohol dependency problems, including driving drunk.

“Our study suggests that we should not be overly concerned about everyday adult use in a legalized environment. But no drug is risk-free,” said John Hewitt, professor of psychology and neuroscience at CU Boulder.

While the study found no adverse effects on the daily lives of cannabis-consuming adults, the study also found no evidence that legal cannabis benefited people’s cognitive, psychological, social, relationship, or financial status.

Overall, the study seems to suggest the same thing we have before. Substances are neutral. It is the person who can choose to use or abuse them. But the drugs themselves have no innate power of control.





Source link

Continue Reading

All about Cannabis

Health Canada: Let’s Ban Potent Cannabis Extracts  – Cannabis | Weed | Marijuana

Published

on

By


Despite a healthcare system already on the verge of collapse pre-COVID, Health Canada bureaucrats have focused on cannabis companies selling extracts.

Health Canada recently requested federally licensed cannabis companies to discontinue the sale of cannabis products the bureaucracy considers mislabeled. Health Canada is concerned adults are consuming products labelled “extracts” as “edibles.”

The move is expected to cost cannabis companies millions of dollars. And it comes at a time when most publicly traded cannabis producers are still losing money.

Why target products that have been on the market for three years? Health Canada has not responded to any media on the topic, including Cannabis Life Network’s request for clarification.

Health Canada: Let's Ban Cannabis Extracts 

While Health Canada’s targeting of cannabis extracts surprises many, others, like CLN, have been expecting this move for a while.

In the letter seen by MJBizDaily, Health Canada said that “upon further review of the products in question, Health Canada has assessed that this product is edible cannabis and, consequently, it contains a quantity of THC that exceeds the allowable limit of 10 mg per immediate container.”

The letter goes on to define “extract,” “edible,” and “food.”

“Health Canada has determined that (the products in question) are consumed in the same manner as food, and therefore fit the definition of edible cannabis,” the Health Canada letter says.

Cannabis extracts cannot exceed 1,000 milligrams per container, one hundred times more than Health Canada permits in the edible class. Ergo, companies would instead produce extracts than edibles.

However, the line has gotten blurred, and this is likely what concerns the bureaucracy’s busybodies. For example, New Brunswick-based cannabis producer Organigram has a “Jolts” product advertised as a lozenge. While each candy is 10mg, the entire pack of 100mg.

Likewise, Redecan has a cannabis extract containing 800 to 1000mg of THC per bottle. However, the oral dispensing syringe caps each “dose” at 8-10mg. 

Are these the products Health Canada wants discontinued?

Health Canada On Extracts: Useless

Health Canada: Let's Ban Cannabis Extracts 

Why Health Canada? And why now? Why at all?

Industry sources expect to lose tens of millions if Health Canada demands extracts and lozenges get pulled from the Canadian cannabis market. They also expect the illicit and legacy markets to fill the void.

Regardless of what you think about public health and safety or an individual’s freedom to consume as much THC as they want, there’s significant concern about how Health Canada is going about this.

This kind of regulatory enforcement is akin to banana republics. Health Canada has already approved these products. Organigram’s “Jolts” have been on the market for over a year.

Producers of these extracts followed all the rules and regulations. And now Health Canada will arbitrarily limit (or ban) these products because… what? Canadian consumers prefer potent extracts over weak-ass edibles?

The lesson here is to remove all THC limits, not bring the hammer down on companies producing legal products. This is not how you regulate an industry.

Infantilizing Adults

While Health Canada hasn’t responded to a request for comment, I suspect the justification will likely be over “public health” and “increased hospitalizations from high-THC products.”

Another way of saying: we’re so bad at delivering health care that instead of improving it, we’re going to start controlling the behaviours that may lead people to need a hospital bed.

That’s the most insulting part of all of this. Health Canada treats adult cannabis consumers like children by limiting their autonomy and decision-making.

Actions speak louder than words. Health Canada bureaucrats (who live off our taxes) lack trust in cannabis-consuming adults to make their own choices and take responsibility for their actions.

When regulations are not based on evidence or are not well-reasoned, they are an infringement on personal liberty and autonomy.

Even with “conventional thinking,” in which government regulations are effective and immune to corruption and politics, it’s essential that regulators balance the need to protect public health and safety with the need to respect adults’ autonomy and decision-making abilities.

Health Canada’s crackdown on cannabis extracts clearly violates that balance. 

This situation would be like if Health Canada discovered that vodka and whiskey were stronger than beer. And so they order distilleries across the nation to arbitrarily limit their alcohol content and take the products off the shelves.

Health Canada has no business regulating cannabis. 

Footnote(s)





Source link

Continue Reading

All about Cannabis

10 Ways Most Cannabis Research is False – Cannabis | Weed | Marijuana

Published

on

By


Most cannabis research is false. A bold statement. So what does it mean? In 2005, Stanford University professor John Ioannidis published the paper “Why Most Published Research Findings Are False.”

In it, he argued that most published research findings are false due to a combination of factors such as small sample sizes, inadequate adjustment for multiple comparisons, and conflicts of interest.

The paper made quite an uproar in the scientific community. While some criticized Ioannidis for simplifying the problem, most agree there is a replication crisis in scientific literature. For example, one study may find cannabis increases the risk of heart attacks. But if no other research can replicate its findings, is the study telling us anything authentic or valid?

The replication crisis doesn’t only affect sociology, medicine or psychology. It also affects cannabis studies. Leading to an uncomfortable conclusion: most cannabis research is false. 

Most Cannabis Research is False

Most Cannabis Research is False

Is most cannabis research false? The replication crisis has led to calls for more transparency and rigour in the research process. But ultimately, the only way out is to evaluate studies based on their replication rate.

Can adolescent cannabis use lead to psychosis or an increased risk of developing schizophrenia? Are cannabis consumers less likely to abuse opioid-based pain medication? Does cannabis make you a more compassionate person? Can it lead to poor cardiovascular health? Will cannabis impair your driving?

Some studies answer in the affirmative, others in the negative. Prohibitionists and public health busybodies like to cite studies that show cannabis’ negative qualities. Proponents of cannabis tend to mention the positive studies.

But most cannabis research is false, whether it confirms your bias or not.

10 Ways Most Cannabis Research is False

The replication crisis has affected studies on cannabis in several ways, including:

  1. Lack of replication: Many studies on cannabis have been criticized for their inability to be replicated. This calls into question the validity of their findings.
  2. Lack of standardization: There is a lack of standardization in the way cannabis is used and administered in studies (not to mention the strains used, their specific cannabinoid content, etc.). This makes it impossible to compare results across different studies.
  3. Small sample sizes: Many studies on cannabis have small sample sizes, which can lead to unreliable results.
  4. Lack of control groups: Some studies on cannabis have lacked proper control groups. This makes it difficult to determine the specific effects of cannabis.
  5. Uncontrolled variables: Many studies on cannabis have not controlled for other factors that could affect the results, such as tobacco use or poor diet. Sometimes, researchers won’t even account for underlying medical conditions.
  6. Limited generalizability: Some researchers conduct studies on cannabis on specific populations, such as patients with a particular medical condition, which can limit the generalizability of the results to the general population.
  7. Publication bias: There is a tendency for researchers to publish positive or negative results than inconclusive results. This leads to an over-representation of “findings” in the literature.
  8. Funding bias: Studies funded by industry stakeholders, such as pharmaceutical companies. This makes the study more likely to produce favourable results than studies funded by other sources. This ultimately creates a bias in the literature.
  9. Lack of transparency: Some studies on cannabis have been criticized for lack of transparency in their methods and results. This makes it challenging to evaluate the robustness of their findings.
  10. Prevalence of observational studies: There is a high prevalence of observational studies in cannabis research, which are prone to bias and confounding. They are less substantial than RCTs (randomized controlled trials) in determining causality.

This overreliance on observational studies means most cannabis research is false. Just as funding bias results in slogans like “Follow the Science,” which is ultimately synonymous with “Follow the Money.”

Studies Say” is the Modern Equivalent to, “The Scriptures Say…”

Most Cannabis Research is False

We’re not here to bash anyone’s spiritual beliefs. If you find solace in Holy Scripture, then all the best. But if you try and argue that your interpretation of the scriptures is describing a reality we all must follow, we’re going to have a problem.

Likewise, we won’t call out anyone using research studies to help navigate the world. You may be on a vegan diet and, therefore, like reading studies confirming the lifestyle’s benefits.

But, once you begin arguing with others that the vegan lifestyle is the only way to live, and you support these opinions by referring to “studies,” then it’s time to step back and reassess.

Both “scriptures” and “studies” express authority or provide evidence for a particular belief or claim.

Scriptures refer to religious texts or teachings considered sacred or authoritative by those who follow that faith. 

Studies, on the other hand, refer to scientific research findings. These are supposed to be based on empirical evidence and subject to rigorous testing, verification, and replication

The failure of much modern research, including cannabis research, to replicate findings is no small matter. That is why most cannabis research is false.

When you read: “Randomized controlled trials evaluating the therapeutic use and safety of marijuana are lacking, but a growing body of evidence suggests that marijuana consumption may be associated with adverse cardiovascular risks.”

You can roll your eyes. There is no “growing body of evidence” because, without RCTs, there is no evidence. Without replication, all you have is an opinion.





Source link

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media